ASMB compared with RCUS: revenue, margins and what each company keeps, and the suppliers and customers both name

ASMBAssembly Biosciences, Inc.

Mkt capRevenueRevenue

RCUSArcus Biosciences, Inc.

Mkt capRevenueRevenue

Compare

ASMBAssembly Biosciences, Inc.

RCUSArcus Biosciences, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ASMB1 of 4 reports

1 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±8.5%▲+10.02%×1.18

RCUS

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±11.2%▲+2.27%×0.21

May 6 '26±18.0%▼−0.23%×0.01

= impliedASMB realized, solidRCUS realized, hatchedOne scale, both sides: full bar = 20%× = |realized| ÷ impliedSource: market data

Q1 FY26

±19.9%

▼−3.60%

×0.18

Oct 29 '25±17.7%▲+2.06%×0.12

ASMBAssembly Biosciences, Inc.

20.16▼−3.36%· post 20.16

Mkt cap$409.9MRevenue$13MQ2 FY26Revenue$72MFY25

RCUSArcus Biosciences, Inc.

18.19▼−2.27%· post 18.19

ClosedOct 30 '26

Mkt cap$2.3BRevenue$41MQ2 FY26Revenue$247MFY25

Compare

ClosedOct 30 '26

ASMBAssembly Biosciences, Inc.

RCUSArcus Biosciences, Inc.

20.16▼−3.36%post 20.16

Price

18.19▼−2.27%post 18.19

$409.9M

Mkt cap

$2.3B

Q2 FY26$13M

Revenue

$41MQ2 FY26

FY25$72M

Revenue

$247MFY25

ASMB20.16▼−3.36%vsRCUS18.19▼−2.27%ClosedOct 30 '26